Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

146 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Completed

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

NCT03512197

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • University of Chicago Medical Center . Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Oregon Health and Science Univ Portland, Oregon, United States
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
View all 133 locations
View Trial Details
Completed

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

NCT03236857

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Disease Attributes, +28 more
Locations
  • Univ California, San Francisco /ID# 163460 San Francisco, California, United States
  • Children's Hospital Colorado /ID# 161551 Aurora, Colorado, United States
  • Children's Healthcare of Atlan /ID# 161552 Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute /ID# 163440 Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Completed

A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

NCT03941964

Conditions
Acute Myeloid Leukemia (AML), Cancer, Hematologic Diseases, +6 more
Locations
  • Arizona Oncology Associates, PC-HOPE /ID# 211509 Tempe, Arizona, United States
  • Colorado Blood Cancer Institute /ID# 212800 Denver, Colorado, United States
  • Rocky Mountain Cancer Centers /ID# 211508 Lone Tree, Colorado, United States
  • Fort Wayne Medical Oncology /ID# 223523 Fort Wayne, Indiana, United States
View all 16 locations
View Trial Details
Completed

Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML

NCT01191957

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Chaim Sheba Medical Center Tel Litwinsky, Israel
  • Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy
  • Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
View all 26 locations
View Trial Details
Completed

Selinexor (KPT-330) in Older Patients With Relapsed AML

NCT02088541

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Jonsson Comprehensive Cancer Center / University of California, Los Angeles Los Angeles, California, United States
  • Sutter Oncology & Hematology Sacramento, California, United States
  • Stanford Cancer Institute / Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute/Sarah Cannon Research Institute Denver, Colorado, United States
View all 78 locations
View Trial Details
Completed

AML-MDS Novel Prognostic Tests Clinical Study

NCT01685619

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details

Related conditions